Back to Search
LAURI SEYMOUR, MD
MD
Internal Medicine Physician
NPI: 1114954187Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Phase II studies of polymer-doxorubicin (PK1, FCE28068) in the treatment of breast, lung and colorectal cancer.
PMID 19424581·Int J Oncol·2009
3-trial
Parasitism of Lygus spp. nymphs by the parasitoid wasp, Peristenus howardi, in the alfalfa seed-growing region of the Pacific Northwest.
PMID 17119626·J Insect Sci·2005
7-preclinical
Glycoviruses: chemical glycosylation retargets adenoviral gene transfer.
PMID 15688429·Angew Chem Int Ed Engl·2005
8-other
Adenovirus retargeting and systemic delivery.
PMID 12894454·Ernst Schering Res Found Workshop·2003
6-review
Epidermal growth factor receptor inhibitors: an update on their development as cancer therapeutics.
PMID 12901223·Curr Opin Investig Drugs·2003
6-review
The design of clinical trials for new molecularly targeted compounds: progress and new initiatives.
PMID 12369856·Curr Pharm Des·2002
6-review
Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicin.
PMID 11896118·J Clin Oncol·2002
3-trial
A review of dose-limiting events in phase I trials: antimetabolites show unpredictable relationships between dose and toxicity.
PMID 11221956·Cancer Chemother Pharmacol·2001
4-observational
Epidermal growth factor receptor as a target: recent developments in the search for effective new anti-cancer agents.
PMID 11469715·Curr Drug Targets·2001
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9900 TALBERT AVE, SUITE 201
FOUNTAIN VALLEY, CA 92708 - Phone
- (714) 965-2500
Quick Facts
- NPI
- 1114954187
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile